Nephro-Urology Monthly

Published by: Kowsar

Adherence to Antihypertensives in Patients With Comorbid Condition

Zahra Saadat 1 , Farahnaz Nikdoust 2 , Hossein Aerab-Sheibani 3 , Mostafa Bahremand 4 , * , Elham Shobeiri 5 , Habibollah Saadat 1 , Yashar Moharramzad 1 and Donald E. Morisky 6
Authors Information
1 Department of Cardiology, Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Cardiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
3 Department of Cardiology, Shahid Sadoughi University of Medical Sciences, Bafgh,Kermanshah, IR Iran
4 Department of Cardiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
5 Department of Radiology, Kermanshah University of Medical Sciences,Kermanshah, IR Iran
6 Department of Community Health Sciences, UCLA Fielding School of Public Health, Los Angeles, USA
Article information
  • Nephro-Urology Monthly: July 01, 2015, 7 (4); e29863
  • Published Online: July 30, 2015
  • Article Type: Research Article
  • Received: May 10, 2015
  • Revised: July 28, 2015
  • Accepted: July 11, 2015
  • DOI: 10.5812/numonthly.29863

To Cite: Saadat Z, Nikdoust F, Aerab-Sheibani H, Bahremand M, Shobeiri E, et al. Adherence to Antihypertensives in Patients With Comorbid Condition, Nephro-Urol Mon. 2015 ; 7(4):e29863. doi: 10.5812/numonthly.29863.

Copyright © 2015, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353(5): 487-97[DOI][PubMed]
  • 2. Delamater AM. Improving patient adherence. Clin Diabetes. 2006; 24(2): 71-7
  • 3. Carretero OA, Oparil S. Essential hypertension : part II: treatment. Circulation. 2000; 101(4): 446-53[PubMed]
  • 4. Krousel-Wood M, Islam T, Muntner P, Holt E, Joyce C, Morisky DE, et al. Association of depression with antihypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO. Ann Behav Med. 2010; 40(3): 248-57[DOI][PubMed]
  • 5. Ghembaza MA, Senoussaoui Y, Tani MK, Meguenni K. Impact of patient knowledge of hypertension complications on adherence to antihypertensive therapy. Curr Hypertens Rev. 2014; 10(1): 41-8[PubMed]
  • 6. An J, Nichol MB. Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension. Med Care. 2013; 51(10): 879-87[DOI][PubMed]
  • 7. Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008; 28(4): 437-43[DOI][PubMed]
  • 8. Scalco AZ, Scalco MZ, Azul JBS, Lotufo Neto F. Hypertension and depression. Clinics. 2005; 60(3): 241-50
  • 9. Natarajan N, Putnam W, Van Aarsen K, Beverley Lawson K, Burge F. Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension. Can Fam Physician. 2013; 59(2)[PubMed]
  • 10. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006; 166(17): 1836-41[DOI][PubMed]
  • 11. Friedman O, McAlister FA, Yun L, Campbell NR, Tu K, Canadian Hypertension Education Program Outcomes Research T. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in ontario. Am J Med. 2010; 123(2): 173-81[DOI][PubMed]
  • 12. Schmittdiel JA, Uratsu CS, Karter AJ, Heisler M, Subramanian U, Mangione CM, et al. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008; 23(5): 588-94[DOI][PubMed]
  • 13. Inkster ME, Donnan PT, MacDonald TM, Sullivan FM, Fahey T. Adherence to antihypertensive medication and association with patient and practice factors. J Hum Hypertens. 2006; 20(4): 295-7[DOI][PubMed]
  • 14. Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol. 2011; 64(3): 255
  • 15. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008; 10(5): 348-54[PubMed]
  • 16. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009; 15(1): 59-66[PubMed]
  • 17. Moharamzad Y, Saadat H, Nakhjavan Shahraki B, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian Version of the 8-Item Morisky Medication Adherence Scale (MMAS-8) in Iranian Hypertensive Patients. Glob J Health Sci. 2015; 7(4): 41252[DOI][PubMed]
  • 18. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67(6): 2089-100[DOI][PubMed]
  • 19. Sarayani A, Jahangard-Rafsanjani Z, Hadjibabaie M, Ahmadvand A, Javadi M, Gholami K. A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. J Diabetes Metab Disord. 2013; 12(1): 57[DOI][PubMed]
  • 20. Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005; 165(10): 1147-52[DOI][PubMed]
  • 21. Breitscheidel L, Ehlken B, Kostev K, Oberdiek MS, Sandberg A, Schmieder RE. Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany. J Med Econ. 2012; 15(1): 155-65[DOI][PubMed]
  • 22. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006; 296(21): 2563-71[DOI][PubMed]
  • 23. Mant J, McManus RJ. Does it matter whether patients take their antihypertensive medication as prescribed? The complex relationship between adherence and blood pressure control. J Hum Hypertens. 2006; 20(8): 551-3[DOI][PubMed]
  • 24. Hacihasanoglu Asilar R, Gozum S, Capik C, Morisky DE. Reliability and validity of the Turkish form of the eight-item Morisky medication adherence scale in hypertensive patients. Anadolu Kardiyol Derg. 2014; 14(8): 692-700[DOI][PubMed]
  • 25. de Oliveira-Filho AD, Morisky DE, Neves SJ, Costa FA, de Lyra DJ. The 8-item Morisky Medication Adherence Scale: validation of a Brazilian-Portuguese version in hypertensive adults. Res Social Adm Pharm. 2014; 10(3): 554-61[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments